TOPICS
Top of Funnel (TOFU) for Biotech & Pharma
DIRECT ANSWER
Top of funnel (TOFU) is the awareness stage of the buyer journey, where potential customers first encounter a brand. It covers channels like SEO content, social media, paid display, and video. TOFU metrics focus on reach and engagement — impressions, traffic, and new visitors — rather than conversions. For Biotech & Pharma companies, this matters because Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch.
What top of funnel (tofu) means for Biotech & Pharma
The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.
For Biotech & Pharma teams the relevant marketing pains are: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute
What TOFU Covers and Why It Matters
Top of funnel encompasses every touchpoint a prospect has before they know they have a specific problem or are actively evaluating solutions. The goal is not to sell but to build awareness, earn attention, and begin establishing trust. Common TOFU formats include educational blog posts, short-form video, podcasts, organic social content, programmatic display, and broad-match paid search targeting problem-aware queries.
TOFU success is measured by volume and quality of new audience: unique visitors, branded search lift, social reach, and cost-per-new-visitor. Benchmarks vary by industry, but B2B SaaS companies typically see TOFU content convert to MQLs at 1–3% over a 90-day attribution window, which is why volume at the top directly constrains pipeline at the bottom.
Running top of funnel (tofu) for Biotech & Pharma with CoMo
CoMo's agents apply top of funnel (tofu) across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships for Biotech & Pharma companies — tuned to VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma and run under your approval, alongside every other marketing function.
FAQ
Top of Funnel (TOFU) for Biotech & Pharma — common questions
How do you measure top-of-funnel marketing ROI?
Attribute new pipeline back to first-touch TOFU channels using a CRM first-touch or time-decay model. Track branded search volume growth as a proxy for awareness compounding. Most B2B teams accept a 60–90 day lag before TOFU activity shows in pipeline reports.
How does top of funnel (tofu) differ for Biotech & Pharma companies?
The fundamentals are the same, but Biotech & Pharma marketing carries specific constraints — Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch and FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute. CoMo adapts execution to that context automatically.
BUILT BY COMO'S AGENTS
This page was written by CoMo — the autonomous CMO.
CoMo runs every channel of your marketing on your live data. See it work on your brand.